Anthony Tumber
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 2%
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
Papers in
-
- Cancer, Hypoxia, and Metabolism 39
-
- Epigenetics and DNA Methylation 46
- Histone Deacetylase Inhibitors Research 28
- Cancer-related gene regulation 21
- RNA modifications and cancer 11
- Protein Degradation and Inhibitors 9
- Co-authors
- Christopher John Schofield (67 shared papers)Peter A. Hill (4 shared papers)Murray C. Meikle (5 shared papers)Udo Oppermann (12 shared papers)Akane Kawamura (23 shared papers)Lennart Brewitz (22 shared papers)Peter Buhl Jensen (2 shared papers)James W.A. Ritchie (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (14 papers)ChemMedChem (9 papers)Chemical Communications (6 papers)Angewandte Chemie International Edition (6 papers)Journal of Biological Chemistry (5 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Anthony Tumber
110 papers receiving 6.2k citations
Anthony Tumber's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 1.0k
- Molecular Biology 4.7k
- Hematology 442
- Oncology 776
- Biochemistry 173
Countries citing papers authored by Anthony Tumber
This map shows the geographic impact of Anthony Tumber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Tumber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Tumber more than expected).
Fields of papers citing papers by Anthony Tumber
This network shows the impact of papers produced by Anthony Tumber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Tumber. The network helps show where Anthony Tumber may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Tumber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response Hit paper breakdown → | 2012 | 790 |
| 2 | 2007 | 626 | |
| 3 | 2014 | 249 | |
| 4 | 2015 | 204 | |
| 5 | 1997 | 199 | |
| 6 | 2017 | 198 | |
| 7 | 2021 | 195 | |
| 8 | 2016 | 165 | |
| 9 | 2016 | 152 | |
| 10 | 2013 | 149 | |
| 11 | 2014 | 137 | |
| 12 | 2011 | 135 | |
| 13 | 2012 | 129 | |
| 14 | 2017 | 123 | |
| 15 | 2013 | 120 | |
| 16 | 2014 | 119 | |
| 17 | Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors Hit paper breakdown → | 2023 | 118 |
| 18 | 2017 | 113 | |
| 19 | 2013 | 109 | |
| 20 | 2013 | 102 |
About Anthony Tumber
Anthony Tumber is a scholar working on Cancer Research, Molecular Biology, Biochemistry, Computational Theory and Mathematics and Oncology, having authored 114 papers that have together received 6.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (46 papers), Cancer, Hypoxia, and Metabolism (39 papers), Histone Deacetylase Inhibitors Research (28 papers), Cancer-related gene regulation (21 papers), RNA modifications and cancer (11 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Protein Degradation and Inhibitors (9 papers) and Computational Drug Discovery Methods (8 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (4.7k citations), Hematology (442 citations), Oncology (776 citations) and Biochemistry (173 citations). Anthony Tumber has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Christopher John Schofield, Peter A. Hill, Murray C. Meikle, Udo Oppermann, Akane Kawamura, Lennart Brewitz, Peter Buhl Jensen, James W.A. Ritchie, Maxwell Sehested and Laura S. Collins. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Chemical Communications, Angewandte Chemie International Edition and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.